In line with this, study conducted in neural progenitor cells derived from iPS cells of WS1 patients demonstrated that pharmacological inhibition of RyR can prevent cell death caused by WFS1 mutation [46]. Here, WFS1 is linked to Waardenburg syndrome type 1.